Global Apomorphine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

According to APO Research, The global Apomorphine Hydrochloride market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Apomorphine Hydrochloride include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical and Sunovion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apomorphine Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Apomorphine Hydrochloride, also provides the sales of main regions and countries. Of the upcoming market potential for Apomorphine Hydrochloride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apomorphine Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Apomorphine Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Apomorphine Hydrochloride sales, projected growth trends, production technology, application and end-user industry.


Apomorphine Hydrochloride Segment by Company

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

Apomorphine Hydrochloride Segment by Type

Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)

Apomorphine Hydrochloride Segment by Application

Parkinson Disease
Erectile Dysfunction

Apomorphine Hydrochloride Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Apomorphine Hydrochloride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Apomorphine Hydrochloride Market Size, 2020 VS 2024 VS 2031
1.3 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts (2020-2031)
1.4 Global Apomorphine Hydrochloride Sales Estimates and Forecasts (2020-2031)
1.5 Global Apomorphine Hydrochloride Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Apomorphine Hydrochloride Market Dynamics
2.1 Apomorphine Hydrochloride Industry Trends
2.2 Apomorphine Hydrochloride Industry Drivers
2.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
2.4 Apomorphine Hydrochloride Industry Restraints
3 Apomorphine Hydrochloride Market by Manufacturers
3.1 Global Apomorphine Hydrochloride Revenue by Manufacturers (2020-2025)
3.2 Global Apomorphine Hydrochloride Sales by Manufacturers (2020-2025)
3.3 Global Apomorphine Hydrochloride Average Sales Price by Manufacturers (2020-2025)
3.4 Global Apomorphine Hydrochloride Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Apomorphine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Apomorphine Hydrochloride Manufacturers, Product Type & Application
3.7 Global Apomorphine Hydrochloride Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Apomorphine Hydrochloride Market CR5 and HHI
3.8.2 Global Top 5 and 10 Apomorphine Hydrochloride Players Market Share by Revenue in 2024
3.8.3 2024 Apomorphine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Apomorphine Hydrochloride Market by Type
4.1 Apomorphine Hydrochloride Type Introduction
4.1.1 Injection
4.1.2 Tablets
4.1.3 Thinfilm
4.1.4 Nasal Powder (Pipeline)
4.2 Global Apomorphine Hydrochloride Sales by Type
4.2.1 Global Apomorphine Hydrochloride Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Apomorphine Hydrochloride Sales by Type (2020-2031)
4.2.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2031)
4.3 Global Apomorphine Hydrochloride Revenue by Type
4.3.1 Global Apomorphine Hydrochloride Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Apomorphine Hydrochloride Revenue by Type (2020-2031)
4.3.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2031)
5 Apomorphine Hydrochloride Market by Application
5.1 Apomorphine Hydrochloride Application Introduction
5.1.1 Parkinson Disease
5.1.2 Erectile Dysfunction
5.2 Global Apomorphine Hydrochloride Sales by Application
5.2.1 Global Apomorphine Hydrochloride Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Apomorphine Hydrochloride Sales by Application (2020-2031)
5.2.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2020-2031)
5.3 Global Apomorphine Hydrochloride Revenue by Application
5.3.1 Global Apomorphine Hydrochloride Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Apomorphine Hydrochloride Revenue by Application (2020-2031)
5.3.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2020-2031)
6 Global Apomorphine Hydrochloride Sales by Region
6.1 Global Apomorphine Hydrochloride Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Apomorphine Hydrochloride Sales by Region (2020-2031)
6.2.1 Global Apomorphine Hydrochloride Sales by Region (2020-2025)
6.2.2 Global Apomorphine Hydrochloride Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Apomorphine Hydrochloride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Apomorphine Hydrochloride Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Apomorphine Hydrochloride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Apomorphine Hydrochloride Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Apomorphine Hydrochloride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Apomorphine Hydrochloride Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Apomorphine Hydrochloride Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Apomorphine Hydrochloride Revenue by Region
7.1 Global Apomorphine Hydrochloride Revenue by Region
7.1.1 Global Apomorphine Hydrochloride Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Apomorphine Hydrochloride Revenue by Region (2020-2025)
7.1.3 Global Apomorphine Hydrochloride Revenue by Region (2026-2031)
7.1.4 Global Apomorphine Hydrochloride Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Apomorphine Hydrochloride Revenue (2020-2031)
7.2.2 North America Apomorphine Hydrochloride Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Apomorphine Hydrochloride Revenue (2020-2031)
7.3.2 Europe Apomorphine Hydrochloride Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Apomorphine Hydrochloride Revenue (2020-2031)
7.4.2 Asia-Pacific Apomorphine Hydrochloride Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Apomorphine Hydrochloride Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Apomorphine Hydrochloride Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Supernus Pharmaceuticals
8.1.1 Supernus Pharmaceuticals Comapny Information
8.1.2 Supernus Pharmaceuticals Business Overview
8.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
8.1.5 Supernus Pharmaceuticals Recent Developments
8.2 Britannia Pharmaceuticals STADA
8.2.1 Britannia Pharmaceuticals STADA Comapny Information
8.2.2 Britannia Pharmaceuticals STADA Business Overview
8.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
8.2.5 Britannia Pharmaceuticals STADA Recent Developments
8.3 Ever Pharma
8.3.1 Ever Pharma Comapny Information
8.3.2 Ever Pharma Business Overview
8.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
8.3.5 Ever Pharma Recent Developments
8.4 Evolan Pharma AB (PharmSwed)
8.4.1 Evolan Pharma AB (PharmSwed) Comapny Information
8.4.2 Evolan Pharma AB (PharmSwed) Business Overview
8.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
8.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
8.5 Tianjin Tianwei Pharmaceutical
8.5.1 Tianjin Tianwei Pharmaceutical Comapny Information
8.5.2 Tianjin Tianwei Pharmaceutical Business Overview
8.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
8.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
8.6 Sunovion
8.6.1 Sunovion Comapny Information
8.6.2 Sunovion Business Overview
8.6.3 Sunovion Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
8.6.5 Sunovion Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Apomorphine Hydrochloride Value Chain Analysis
9.1.1 Apomorphine Hydrochloride Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Apomorphine Hydrochloride Production Mode & Process
9.2 Apomorphine Hydrochloride Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Apomorphine Hydrochloride Distributors
9.2.3 Apomorphine Hydrochloride Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings